Acadia Healthcare Company, Inc. (ACHC) Form 10-Q — Nov 4, 2026
Acadia Healthcare's Q3 2026 revenue rose 5.1% to $895.3 million on same-facility growth of 5.2%, but net income attributable to the company slipped to $34.5 million ($0.38 diluted EPS) from $36.2 million a year ago. The nine-month picture is weaker: net income attributable to Acadia fell to $49.5 million from $74.7 million, pressured by a 38.1% effective tax rate (vs 17.5%), a $28.6 million unfavorable actuarial adjustment to its professional liability reserve, and $10.9 million of property impairments.
Key figures
- Eps
- 0.38
- Revenue
- 895309000
- Net Income
- 34486000
- Revenue Yoy
- 5.1% (Q3); 4.0% (nine months)
- Total Assets
- 5554590000
- Cash Position
- 163307000
- Shares Outstanding
- 92966685
- Q3 2025 revenue
- 851573000
- Nine month revenue
- 2589950000
- Q3 effective tax rate
- 31.6%
- Nine month eps diluted
- 0.54
- Credit facility carrying
- 888236000
- Prior year nine month eps
- 0.82
- Nine month effective tax rate
- 38.1%
- Professional liability reserve
- 214700000
- Operating cash flow nine months
- 321500000
- Same facility revenue growth q3
- 5.2%
- Nine month prior year net income
- 74747000
- Nine month net income attributable
- 49519000
- Share repurchase authorization remaining
- 250000000
AI analysis
Red flags8 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.